Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 12:33 PM

Synthes Inc

Type: Company
Name: Synthes Inc
Nationality: Switzerland
Fact Sheet: Fact Sheet for Synthes, Inc.
First Reported 11/11/2009 - Updated 11/12/2009 - 5 Documents
FDA regulatory clearance for Kensey Nash's ECM product
Kensey Nash Corporation (Nasdaq: KNSY), a leading medical technology company that provides innovative resorbable biomaterial technology for a wide range of medical procedures, today announced that it has received 510(k) clearance for its first extracellular ... [News-Medical.Net - 11/12/2009]
First Reported 11/09/2009 - Updated 11/09/2009 - 3 Documents
Research and Markets: Switzerland's Medical Equipment & Supplies Market Is Estimated To Be Approximately US$4.1 Billion In 2009
DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/7dea86/the_medical_device) has announced the addition of the 'The Medical Device Market: Switzerland' report to their offering. This in-depth medical device market ... [Yahoo! Canada - 11/09/2009]
First Reported 11/04/2009 - Updated 11/04/2009 - 1 Documents (in Biology)
Synthes recalling spinal implant
Synthes Inc., West Chester, said some of its spinal implants, used to replace vertebrae damaged by cancer or fractures, may fail and put patients at risk for pain, nerve damage and repeat surgery. The Food and Drug Administration deemed the company's ... [Philadelphia Inquirer - 11/04/2009]
First Reported 11/05/2009 - Updated 11/05/2009 - 1 Documents
Food and Drug Administration - Click to view 360-page
Food and Drug Administration
BRIEF-Synthes indicated to fall after FDA says devices are health hazard
ZURICH, Nov 5 (Reuters) - Synthes Inc:* Shares indicated to open 3.4 percent lower after FDA says recalled Synthesdevices are health Hazard((Zurich Newsroom, zurich.newsroom@reuters.com, +41 58 306 7336))(For more information, click on)COPYRIGHT ... [Forbes.com - 11/05/2009]
First Reported 11/05/2009 - Updated 11/05/2009 - 1 Documents
Chrysler LLC - Click to view 360-page
Chrysler LLC
Business news in brief
In the Region J&J to close 2 area sites Johnson & Johnson said yesterday that it was closing research-and-development facilities in Radnor and Chesterbrook and consolidating those operations at its Spring House site. The New Brunswick, N.J., company would ... [Philadelphia Inquirer - 11/05/2009]
First Reported 09/07/2009 - Updated 09/07/2009 - 2 Documents (in Conflicts & Crime)
U.S. court backs Synthes in U.S. patent case
ZURICH (Reuters) - Switzerland-based medical device maker Synthes Inc has won a key ruling in an ongoing U.S. patent case against U.S. competitor Medtronic, the Swiss company said on Monday. ... [Reuters: Business News - 09/07/2009]
First Reported 10/14/2009 - Updated 10/14/2009 - 2 Documents (in Corporate Deals)
Reportlinker Adds China Orthopedic Devices Investment Opportunities, Analysis and Forecasts to...
China Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2012http://www.reportlinker.com/p0101173/China-Orthopedic-Devices-Investment-Opportunities-Analysis-and-Forecasts-to-2012.htmlChina Orthopedic Devices Investment Opportunities, ... [Forbes.com - 10/14/2009]
First Reported 10/16/2009 - Updated 10/16/2009 - 1 Documents (in Corporate Deals)
Round Table, Pt. 3: Managers' stock picks
The third and final installment of Buy and Sell columnist Jonathan Ratner's U.S. and global equity round table as well as stock picks from Stephen Way of AGF Funds, Dana Love and Heather Peirce from Invesco Trimark, Alex Lane of Dynamic Funds, and Ray ... [Financial Post - 10/16/2009]
First Reported 10/21/2009 - Updated 10/21/2009 - 1 Documents
Synthes Q3 sales rise 7.5 pct, confirms guidance
ZURICH, Oct 21 (Reuters) - Swiss medical device maker Synthes Inc(SYST.VX) posted a 7.5 percent rise in sales in the third quarter, meeting analysts' expectations, as a recovery in the U.S. market added to strong demand growth in Asia and Europe.The maker ... [Reuters UK - 10/21/2009]
First Reported 10/21/2009 - Updated 10/21/2009 - 1 Documents
Synthes 3Q Sales Up 7.5%, Sees 2009 Sales Growth
ZURICH -(Dow Jones)- Switzerland-listed surgical implant and device company Synthes Inc. (SYST.VX) Wednesday confirmed its 2009 goals as it reported a stronger-than expected 7.5% rise in third-quarter sales, helped by new products and strong volumes in ... [CNN Money - 10/21/2009]
First Reported 06/17/2009 - Updated 06/17/2009 - 1 Documents (in Conflicts & Crime)
Indictment says W. Chester firm tested cement on patients
A Swiss company with major operations in West Chester illegally tested its bone cement on about 200 people, three of whom died, according to a 52-count indictment issued yesterday by the U.S. attorney in Philadelphia.Synthes Inc., a producer of orthopedic ... [Philadelphia Inquirer - 06/17/2009]
First Reported 08/14/2009 - Updated 08/14/2009 - 1 Documents
Synthes exec pleads guilty in bone-cement case
A fourth Synthes Inc. executive today pleaded guilty in Philadelphia to charges stemming from illegal clinical trials of a bone cement. Three people died in connection with the experimental surgeries.Richard E. Bohner admitted to shipping misbranded Norian ... [Philadelphia Inquirer - 08/14/2009]

More Content

All (27) | News (25) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (1)
sort by: Date | Relevance
FDA regulatory clearance for Kensey Nash's ECM ... [News-Medical.Net - 11/12/2009]
Kensey Nash gets FDA 510(k) clearance for Medeo... [Pharmacy Choice - 11/12/2009]
Kensey Nash Receives FDA 510(k) Clearance for P... [Yahoo! Canada - 11/11/2009]
Kensey Nash Receives FDA 510(k) Clearance for P... [PR Newswire via MSN Money - 11/11/2009]
Kensey Nash Receives FDA 510(k) Clearance for P... [Stockwatch - 11/11/2009]
IT Executives Cite Business Continuity, Risk Ma... [Red Orbit - 11/10/2009]
IT Executives Cite Business Continuity, Risk Ma... [PR Newswire - 11/09/2009]
IT Executives Cite Business Continuity, Risk Ma... [Freshnews.com - 11/09/2009]
Research and Markets: Switzerland's Medical Equ... [Yahoo! Canada - 11/09/2009]
Research and Markets: Switzerland's Medical Equ... [RBC Dain Rauscher - 11/09/2009]
Research and Markets: Switzerland's Medical Equ... [Business Wire - 11/09/2009]
Business news in brief [Philadelphia Inquirer - 11/05/2009]
BRIEF-Synthes indicated to fall after FDA says ... [Forbes.com - 11/05/2009]
Synthes recalling spinal implant [Philadelphia Inquirer - 11/04/2009]
Synthes 3Q Sales Up 7.5%, Sees 2009 Sales Growth [CNN Money - 10/21/2009]
Synthes Q3 sales rise 7.5 pct, confirms guidance [Reuters UK - 10/21/2009]
Round Table, Pt. 3: Managers' stock picks [Financial Post - 10/16/2009]
Reportlinker Adds China Orthopedic Devices Inve... [Forbes.com - 10/14/2009]
Reportlinker Adds China Orthopedic Devices Inve... [Business Wire - 10/14/2009]
Reportlinker Adds United States Medical Equipme... [Business Wire - 10/13/2009]
U.S. court backs Synthes in U.S. patent case [Reuters: Business News - 09/07/2009]
U.S. court backs Synthes in U.S. patent case [Reuters: U.S. - 09/07/2009]
Synthes exec pleads guilty in bone-cement case [Philadelphia Inquirer - 08/14/2009]
Indictment says W. Chester firm tested cement o... [Philadelphia Inquirer - 06/17/2009]
Even now, some of the rich getting richer [Philadelphia Inquirer - 03/15/2009]
1
In Focus
  •  
John Walsh, Michael Kessler, Jeffrey Lurie, [more]
  •  
Kensey Nash Corporation, Medtronic Inc, Diagnostic Imaging Group LLC, [more]
  •  
Food and Drug Administration, CE Mark, European Union, [more]
  •  
Patent, Health Hazard, Pleading, [more]
  •  
Solothurn (Switzerland), Philadelphia (Pennsylvania, United St ..., Miami (Florida, United States), [more]
  •  
United States, Switzerland, China, [more]
  •  
Court Cases, Internet & IT, Research & Development, [more]
  •  
Pharma & Biotech, Health, IT, [more]
Philadelphia Inquirer, Able2Act, Reuters: Business News, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
On Bone Cement and the Law [WSJ.com: Law Blog - 06/17/2009]
Rest assured, we’ll give a close look to any article containing repeated references to “bone cement.” But because this WSJ article also has a legal angle, we’re ...
1

  •  
  •  
  •